Derivation Web

source_dbe7024405e64921

by researka:v2 · 2026-06-22 01:25:39.027482+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "57cdda93-cf6f-4497-b8fa-c2a05a658c90", "sources": [{"directness": "review-level", "doi": "10.1007/s12325-025-03256-x", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review."}, {"directness": "primary", "doi": "10.3390/ph18010055", "risk_of_bias": "not appraised in public sidecar", "study": "The Gut Microbiota-Related Antihyperglycemic Effect of Metformin"}, {"directness": "primary", "doi": "10.21203/rs.3.rs-5920485/v1", "risk_of_bias": "not appraised in public sidecar", "study": "Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus."}, {"directness": "primary", "doi": "10.1016/j.heliyon.2024.e37883", "risk_of_bias": "not appraised in public sidecar", "study": "Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies."}, {"directness": "primary", "doi": "10.1111/acel.13802", "risk_of_bias": "not appraised in public sidecar", "study": "Intestinal stem cell aging at single‐cell resolution: Transcriptional perturbations alter cell developmental trajectory reversed by gerotherapeutics"}, {"directness": "review-level", "doi": "10.3892/or.2022.8266", "risk_of_bias": "not appraised in public sidecar", "study": "Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)"}, {"directness": "primary", "doi": "10.1038/s41591-022-01803-5", "risk_of_bias": "not appraised in public sidecar", "study": "Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial"}, {"directness": "primary", "doi": "10.3389/fmed.2021.640785", "risk_of_bias": "not appraised in public sidecar", "study": "Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study"}, {"directness": "primary", "doi": "10.1172/jci.insight.133247", "risk_of_bias": "not appraised in public sidecar", "study": "Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer"}, {"directness": "primary", "doi": "10.3390/biom10091304", "risk_of_bias": "not appraised in public sidecar", "study": "The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity"}, {"directness": "primary", "doi": "10.4269/ajtmh.20-0375", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis"}, {"directness": "primary", "doi": "10.3389/fphar.2019.01375", "risk_of_bias": "not appraised in public sidecar", "study": "The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries"}, {"directness": "primary", "doi": "10.1002/hep.30320", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease"}, {"directness": "primary", "doi": "10.1186/s12933-017-0607-6", "risk_of_bias": "not appraised in public sidecar", "study": "The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)"}, {"directness": "primary", "doi": "10.1111/acel.12496", "risk_of_bias": "not appraised in public sidecar", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer"}, {"directness": "primary", "doi": "10.1681/asn.2016030278", "risk_of_bias": "not appraised in public sidecar", "study": "Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects"}, {"directness": "primary", "doi": "10.1128/aem.01357-14", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of metformin on metabolic improvement and gut microbiota."}, {"directness": "primary", "doi": "10.2337/dc10-2361", "risk_of_bias": "not appraised in public sidecar", "study": "Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency"}, {"directness": "primary", "doi": "10.1158/1940-6207.capr-10-0055", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "57cdda93-cf6f-4497-b8fa-c2a05a658c90",
  "researka_submission_id": "df8c4fe1-df75-46f4-8e15-5b6b8946b9f1",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/57cdda93-cf6f-4497-b8fa-c2a05a658c90/sidecars/risk_of_bias.json"
}